Skip to main content

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans, LA.  

A live webcast will be available to registered participants. Following the presentation, the webcast replay will be available at https://event.summitcast.com/view/d69xRqMspwymhwGUDdQoes/JC9qqvWhWggYawxGnDNtmz

About Carlsmed, Inc.

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Investor Relations
Caroline Corner, PhD
IR@Carlsmed.com 

Media
LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com


Primary Logo

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  270.87
+3.94 (1.48%)
AAPL  348.51
-2.18 (-0.62%)
AMD  515.21
+6.63 (1.30%)
BAC  50.68
+0.13 (0.26%)
GOOG  284.92
-1.09 (-0.38%)
META  641.39
+0.02 (0.00%)
MSFT  533.16
-12.02 (-2.20%)
NVDA  168.89
-9.78 (-5.47%)
ORCL  117.98
-1.81 (-1.51%)
TSLA  379.78
+1.73 (0.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.